Study suggests insect- and algae-based trout feeds can match standard diets

CURRENT BRIEF VERSION: A new study in Animals reports that practical, lower-dependency aquafeeds built with insect meal, microalgae, single-cell ingredients, selected plant proteins, and aquaculture by-products delivered rainbow trout growth, body composition, nutrient retention, and flesh quality comparable to a conventional control diet. The trial tested four extruded feeds, including a standard formulation and three eco-efficient alternatives: one without processed animal proteins, one with them, and one mixed strategy. The broader finding fits with a growing body of trout and other aquaculture research showing that insect- and algae-based ingredients can replace part of the sector’s reliance on fishmeal and fish oil without a clear performance penalty when diets are carefully balanced. It also aligns with by-product work in other species: in juvenile yellowtail, an Animals feeding trial found that replacing up to 35% of fishmeal protein with shark by-product-based composite mixtures maintained growth and survival, and in some formulations improved feed efficiency, although some diets reduced EPA and DHA levels. (mdpi.com)

Why it matters: For veterinary professionals working in aquaculture, the study adds practical evidence that alternative ingredient stacks, not just single substitutions, can support production targets while preserving fillet quality. That matters because the industry is under pressure to reduce dependence on marine ingredients that face supply constraints, while still maintaining animal performance, welfare, and product quality. The yellowtail data also reinforce an important point for clinicians and nutrition teams: by-product proteins can help reduce fishmeal use without obvious growth losses, but fatty acid profiles still need close attention. EU rules already allow insect-derived processed animal proteins in aquafeeds under defined conditions, which makes this less of a theoretical nutrition story and more of a formulation and scale-up question. (mdpi.com)

What to watch: The next step is whether longer-term, commercial-scale trials can confirm cost, consistency, health outcomes, and fatty acid quality across real farm conditions, not just controlled feeding studies. (mdpi.com)